CALY-002

Indicaton

Celiac Disease, Eosinophilic Esophagitis, Dermatology

Therapeutic indications

Type of product

Antibody

Table

Phase

Phase I started
Partnering status

Not partnered

You may also be interested in

AUP-16 (AUP1602-C)

AUP-16 is a multi-therapy live bacterial vector for chronic wounds: Diabetic Foot, Leg & Pressure Ulcers

Phase II started

Veblocema (infliximab SC)

Multiple indications in rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis and psoriasis

Marketed

Remsima (infliximab IV)

Multiple indications in rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis and psoriasis

Marketed